2-(4-naphthalen-1-ylphenyl)-4-pyren-1-yl-6-(4-pyridin-4-ylphenyl)-1,3,5-triazine
C46H28N4 — CID 130264412
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(4-naphthalen-1-ylphenyl)-4-pyren-1-yl-6-(4-pyridin-4-ylphenyl)-1,3,5-triazine
2-(4-naphthalen-1-ylphenyl)-4-pyren-1-yl-6-(4-pyridin-4-ylphenyl)-1,3,5-triazine (PubChem CID 130264412) has the molecular formula C46H28N4 and a molecular weight of 636.76 g/mol. Its IUPAC name is 2-(4-naphthalen-1-ylphenyl)-4-pyren-1-yl-6-(4-pyridin-4-ylphenyl)-1,3,5-triazine.
Molecular Properties
| Compound Name | 2-(4-naphthalen-1-ylphenyl)-4-pyren-1-yl-6-(4-pyridin-4-ylphenyl)-1,3,5-triazine |
|---|---|
| PubChem CID | 130264412 |
| Molecular Formula | C46H28N4 |
| Molecular Weight | 636.76 g/mol |
| Exact Mass | 636.23 |
| IUPAC Name | 2-(4-naphthalen-1-ylphenyl)-4-pyren-1-yl-6-(4-pyridin-4-ylphenyl)-1,3,5-triazine |
| SMILES | c1ccc2c(-c3ccc(-c4nc(-c5ccc(-c6ccncc6)cc5)nc(-c5ccc6ccc7cccc8ccc5c6c78)n4)cc3)cccc2c1 |
| InChI | InChI=1S/C46H28N4/c1-2-9-38-31(5-1)6-4-10-39(38)32-13-19-37(20-14-32)45-48-44(36-17-11-29(12-18-36)30-25-27-47-28-26-30)49-46(50-45)41-24-22-35-16-15-33-7-3-8-34-21-23-40(41)43(35)42(33)34/h1-28H |
| InChIKey | PDLSAIGAMYQDHT-UHFFFAOYSA-N |
| XLogP | 11.65 |
| TPSA | 51.56 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 636.76 |
| LogP ≤ 5 | 11.65 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 130264412 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.